1
TÍTULO: Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study  Full Text
AUTORES: Kwak, Larry W.; Sancho, Juan Manuel; Cho, Seok Goo; Nakazawa, Hideyuki; Suzumiya, Junji; Tumyan, Gayane; Kim, Jin Seok; Menne, Tobias; Mariz, Jose; Ilyin, Nikolai; Jurczak, Wojciech; Lopez Martinez, Aurelio; Samoilova, Olga; Zhavrid, Edvard; Yanez Ruiz, Eduardo; Trneny, Marek; Popplewell, Leslie; Ogura, Michinori; Kim, Won Seog; Lee, Sang Joon; Kim, Sung Hyun; Ahn, Keum Young; Buske, Christian; ...Mais
PUBLICAÇÃO: 2022, FONTE: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, VOLUME: 22, NÚMERO: 2
INDEXADO EM: Scopus WOS
2
TÍTULO: Phase III Randomized AUGMENT Study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma  Full Text
AUTORES: Gribben, J; Trneny, M; Izutsu, K; Fowler, NH; Hong, X; Zhu, J; Zhang, H; Offner, F; Scheliga, A; Nowakowski, G; Pinto, A; Re, F; Fogliatto, LM; Scheinberg, P; Flinn, I; Moreira, C; Liu, D; Kalambakas, S; Fustier, P; Wu, C; Leonard, JP; ...Mais
PUBLICAÇÃO: 2019, FONTE: 59th Annual Scientific Meeting of the British-Society-for-Hematology in BRITISH JOURNAL OF HAEMATOLOGY, VOLUME: 185
INDEXADO EM: WOS
3
TÍTULO: AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
AUTORES: Leonard, JP; Trneny, M; Izutsu, K; Fowler, NH; Hong, X; Zhu, J; Zhang, H; Offner, F; Scheliga, A; Nowakowski, GS; Pinto, A; Re, F; Fogliatto, LM; Scheinberg, P; Flinn, IW; Moreira, C; Cabeçadas, J; Liu, D; Kalambakas, S; Fustier, P; Wu, C; Gribben, JG; ...Mais
PUBLICAÇÃO: 2019, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, NÚMERO: 14
INDEXADO EM: Scopus WOS
4
TÍTULO: Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project  Full Text
AUTORES: Andy C Rawstron; Karl Anton Kreuzer; Asha Soosapilla; Martin Spacek; Olga Stehlikova; Peter Gambell; Neil McIver Brown; Neus Villamor; Katherina Psarra; Maria Arroz; Raffaella Milani; Javier de la Serna; Teresa Cedena, MT; Ozren Jaksic; Josep Nomdedeu; Carol Moreno; Gian Matteo Rigolin; Antonio Cuneo; Preben Johansen; Hans E Johnsen; Richard Rosenquist; Carsten Utoft Niemann; Wolfgang Kern; David Westerman; Marek Trneny; Stephen Mulligan; Michael Doubek; Sarka Pospisilova; Peter Hillmen; David Oscier; Michael Hallek; Paolo Ghia; Emili Montserrat; ...Mais
PUBLICAÇÃO: 2018, FONTE: CYTOMETRY PART B-CLINICAL CYTOMETRY, VOLUME: 94, NÚMERO: 1
INDEXADO EM: WOS
5
TÍTULO: Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial
AUTORES: Michinori Ogura; Juan Manuel Sancho; Seok Goo Cho; Hideyuki Nakazawa; Junji Suzumiya; Gayane Tumyan; Jin Seok Kim; Anne Lennard; Jose Mariz; Nikolai Ilyin; Wojciech Jurczak; Aurelio Lopez Martinez; Olga Samoilova; Edvard Zhavrid; Eduardo Yanez Ruiz; Marek Trneny; Leslie Popplewell; Bertrand Coiffier; Christian Buske; Woo Seog Kim; Sang Joon Lee; Sung Young Lee; Yun Ju Bae; Larry W Kwak; ...Mais
PUBLICAÇÃO: 2018, FONTE: LANCET HAEMATOLOGY, VOLUME: 5, NÚMERO: 11
INDEXADO EM: Scopus WOS
6
TÍTULO: AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
AUTORES: John P Leonard; Marek Trneny; Koji Izutsu; Nathan H Fowler; Xiaonan N Hong; Jun Zhu; Huilai L Zhang; Fritz Offner; Adriana Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian W Flinn; Claudia Moreira; David Liu; Stacey Kalambakas; Pierre Fustier; Chengqing Q Wu; John G Gribben; ...Mais
PUBLICAÇÃO: 2018, FONTE: 60th Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 132
INDEXADO EM: WOS
7
TÍTULO: Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study  Full Text
AUTORES: Martin Dreyling; Wojciech Jurczak; Mats Jerkeman; Rodrigo Santucci Silva; Chiara Rusconi; Marek Trneny; Fritz Offner; Dolores Caballero; Cristina Joao; Mathias Witzens Harig; Georg Hess; Isabelle Bence Bruckler; Seok Goo Cho; John Bothos; Jenna D Goldberg; Christopher Enny; Shana Traina; Sriram Balasubramanian; Nibedita Bandyopadhyay; Steven Sun; Jessica Vermeulen; Aleksandra Rizo; Simon Rule; ...Mais
PUBLICAÇÃO: 2016, FONTE: LANCET, VOLUME: 387, NÚMERO: 10020
INDEXADO EM: Scopus WOS CrossRef
8
TÍTULO: Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
AUTORES: Clementine Sarkozy; Marek Trneny; Luc Xerri; Nick Wickham; Pierre Feugier; Sirpa Leppa; Pauline Brice; Pierre Soubeyran; Maria Gomes Da Silva; Christiane Mounier; Fritz Offner; Jehan Dupuis; Dolores Caballero; Danielle Canioni; Marlton Paula; Richard Delarue; Pierre Zachee; John Seymour; Gilles Salles; Herve Tilly;
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 22
INDEXADO EM: Scopus WOS CrossRef
9
TÍTULO: Subgroup analysis of the phase II randomized MCL-002 (SPRINT) study of lenalidomide vs investigator's choice in relapsed/refractory mantle cell lymphoma
AUTORES: Marek Trneny; Thierry Lamy; Jan Andrzej Walewski; David Belada; Jiri Mayer; John A Radford; Wojciech Jurczak; Franck Morschhauser; Julia Alexeeva; Simon Rule; Tsvetan Nikolov Biyukov; Meera Patturajan; Marie Laure Casadebaig Bravo; Jose Cabecadas; Luca Arcaini;
PUBLICAÇÃO: 2015, FONTE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 33, NÚMERO: 15
INDEXADO EM: WOS
10
TÍTULO: A Randomized Study of Interferon alpha-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma
AUTORES: Andre Bosly; Andrew Grigg; Harald Holte; Christian Gisselbrecht; John Radford; Andrea Rossi; Armando Lopez Guillermo; Marek Trneny; Catherine Sebban; Hans Hagberg; Fernando Leal da Costa; Philippe Colombat; Dominique Bron; Bertrand Coiffier;
PUBLICAÇÃO: 2013, FONTE: ONCOLOGIST, VOLUME: 18, NÚMERO: 11
INDEXADO EM: Scopus WOS CrossRef